The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif

Xiaolei Huang,Cheng Zhang,Xinci Shang,Yichang Chen,Qin Xiao,Zhengguo Wei,Guanghui Wang,Xuechu Zhen,Guoqiang Xu,Jinrong Min,Shaoming Shen,Yanli Liu
DOI: https://doi.org/10.1038/s41419-024-06714-6
2024-05-15
Cell Death and Disease
Abstract:PTENα/β, two variants of PTEN, play a key role in promoting tumor growth by interacting with WDR5 through their N-terminal extensions (NTEs). This interaction facilitates the recruitment of the SET1/MLL methyltransferase complex, resulting in histone H3K4 trimethylation and upregulation of oncogenes such as NOTCH3 , which in turn promotes tumor growth. However, the molecular mechanism underlying this interaction has remained elusive. In this study, we determined the first crystal structure of PTENα-NTE in complex with WDR5, which reveals that PTENα utilizes a unique binding motif of a sequence SSSRRSS found in the NTE domain of PTENα/β to specifically bind to the WIN site of WDR5. Disruption of this interaction significantly impedes cell proliferation and tumor growth, highlighting the potential of the WIN site inhibitors of WDR5 as a way of therapeutic intervention of the PTENα/β associated cancers. These findings not only shed light on the important role of the PTENα/β-WDR5 interaction in carcinogenesis, but also present a promising avenue for developing cancer treatments that target this pathway.
cell biology
What problem does this paper attempt to address?